Trtllc: Softwave Tissue Regeneration Technologies announces landmark trial for acute traumatic spinal cord injuries
SoftWave Tissue Regeneration Technologies, a disruptive bio-medical device company, announces the beginning of a trial for "Extracorporeal Shock Wave Therapy in Acute Traumatic Complete and Incomplete Cross - Sectional Lesions."...Read More
Read full article »
CEO
TRT is a Georgia-based medical technology company that develops and manufactures pressure and shock wave devices for the healthcare industry.
Read more